V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018490 | 270010547 | 1.63 | 56.6 | Curative (C) | null | 2015-08-12 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 270023185 | CTD |
| 270018491 | 270010549 | 1.56 | null | Adjuvant (A) | 2015-12-06 | 2016-03-01 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | null | 270023195 | R-EPOCH |
| 270018492 | 270010552 | 1.82 | 66.3 | null | 2016-11-23 | 2016-11-23 | Nilotinib | 02 | Y | 270023299 | NHL 2003 |
| 270018493 | 270010560 | 1.75 | 79.8 | Curative (C) | 2016-10-24 | 2016-10-28 | ICE | 02 | N | 270023353 | CYCLOPHOSPHAMIDE |
| 270018494 | 270010564 | 1.76 | 117.5 | Curative (C) | 2017-01-10 | 2017-09-09 | DHAP - R | 2 | Y | 270023365 | MELPHALAN |
| 270018495 | 270010567 | 1.58 | 45 | Curative (C) | 2015-02-25 | 2015-02-25 | RATHL TRIAL | 02 | Y | 270023443 | ECHELON 1 TRIAL |
| 270018496 | 270010572 | 1.67 | 84.6 | Disease modification (D) | 2018-04-18 | 2018-05-30 | BLEOMYCIN | Y | N | 270023459 | ICE |
| 270018497 | 270014937 | null | 79.2 | Adjuvant (A) | 2016-03-03 | 2016-03-05 | LENALIDOMIDE | 02 | N | 270023542 | MATRIX TRIAL |
| 270018498 | 270014939 | 1.6 | null | Palliative (P) | 2016-12-13 | 2016-12-26 | ETOPOSIDE | 02 | N | 270023574 | LENALIDOMIDE |
| 270018499 | 270017241 | null | null | Curative (C) | 2015-05-29 | 2015-06-05 | METHOTREXATE | N | N | 270023661 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270018500 | 270010591 | 1.8 | 77 | Palliative (P) | 2017-04-24 | 2017-06-14 | MPT | null | N | 270023690 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270018501 | 270018547 | 1.73 | 55.3 | Curative (C) | 2017-06-23 | 2017-07-04 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE | N | N | 270023710 | DOXORUBICIN |
| 270018502 | 270010600 | null | 65.3 | null | 2016-02-24 | 2016-03-10 | DOXORUBICIN | 02 | null | 270023805 | BORTEZOMIB |
| 270018503 | 270010602 | 0 | 80.1 | Palliative (P) | 2013-09-22 | 2013-11-16 | BEVACIZUMAB + FLUOROURACIL | 02 | N | 270023835 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270018504 | 270017244 | 1.84 | null | Curative (C) | 2018-09-18 | 2018-09-25 | Trastuzumab 21 day maintenance | 02 | N | 270023880 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270018505 | 270014951 | 1.84 | null | Palliative (P) | 2017-10-07 | 2017-11-12 | ICE | null | null | 270024025 | BENDAMUSTINE + THALIDOMIDE |
| 270018506 | 270010615 | null | 53.7 | Palliative (P) | 2015-08-31 | 2015-09-02 | BENDAMUSTINE + Brentuximab Vendotin | 02 | N | 270024115 | DHAP - R |
| 270018507 | 270010617 | 1.64 | 54.4 | Curative (C) | 2015-10-19 | 2016-03-07 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 270024151 | BENDAMUSTINE + THALIDOMIDE |
| 270018508 | 270010621 | 1.72 | 84.2 | Palliative (P) | 2016-05-24 | 2016-06-05 | Bendamustine+Rituximab(Sub Courses) | 01 | N | 270024192 | CHLVPP/PABLOE |
| 270018509 | 270014961 | 1.67 | 67.5 | Curative (C) | 2018-06-05 | 2018-06-12 | Alemtuz+Fludara+Melphalan RIC MUD | N | Y | 270024204 | Y-90 |
| 270018510 | 270010626 | 1.79 | null | Curative (C) | 2016-12-29 | 2017-04-02 | Cyclophosphamide+Fludara+TBI Allo | N | N | 270024216 | IBRUTINIB |
| 270018511 | 270010630 | 1.76 | null | Palliative (P) | 2017-02-15 | 2017-07-18 | LOPP | N | N | 270024270 | ICE |
| 270018512 | 270010632 | 1.68 | 57.3 | Adjuvant (A) | 2015-04-21 | 2015-04-30 | Methotrexate High Dose (3g/m2) | 02 | N | 270024285 | CYCLOPHOSPHAMIDE |
| 270018513 | 270010634 | 1.81 | 101.4 | Neo-adjuvant (N) | 2015-02-01 | 2015-05-12 | BORTEZOMIB + THALIDOMIDE | N | N | 270024329 | CHOP |
| 270018514 | 270014967 | 1.71 | 85 | null | 2017-04-05 | 2017-04-22 | GEMCITABINE + VINORELBINE | null | N | 270024460 | METHOTREXATE INTRATHECAL |
| 270018515 | 270010639 | 1.62 | 86.9 | Adjuvant (A) | 2016-04-02 | 2016-05-06 | ETOPOSIDE | 02 | N | 270024501 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 270018516 | 270010641 | 2 | 67 | Curative (C) | 2018-06-03 | 2018-06-18 | Bendamustine+Rituximab (1st Course) | 02 | N | 270024510 | ICE |
| 270018517 | 270010645 | 1.68 | 116.4 | Curative (C) | 2013-06-02 | 2013-06-02 | ECHELON 1 TRIAL | 02 | N | 270024518 | CISPLATIN + CETUXIMAB |
| 270018518 | 270014972 | 1.8 | 75 | Not known (9) | 2017-03-23 | 2017-03-24 | CVP R | 2 | N | 270024541 | GDCVP |
| 270018519 | 270010654 | 1.6 | 52.3 | Curative (C) | 2016-06-10 | 2016-06-14 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 270024614 | MPT |
| 270018520 | 270010657 | 1.54 | 52.6 | Palliative (P) | 2014-08-08 | 2015-04-22 | Docetaxel 75mg/m2 (21 day) | N | N | 270024662 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270018521 | 270010660 | 1.8 | null | Palliative (P) | 2015-10-06 | 2015-10-06 | CARBOPLATIN + RT | 2 | N | 270024741 | IBRUTINIB |
| 270018522 | 270010664 | 1.6 | null | Palliative (P) | null | 2018-05-11 | Pemetrexed | null | N | 270024754 | CARBOPLATIN + ETOPOSIDE |
| 270018523 | 270010666 | 1.8 | 64.4 | Curative (C) | null | 2018-02-13 | FOXTROT TRIAL | 2 | N | 270024769 | CARBOPLATIN + RT |
| 270018524 | 270010670 | 1.68 | null | Palliative (P) | 2018-05-07 | 2019-01-09 | R CODOX-M/ R IVAC | N | N | 270024790 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 270018525 | 270010679 | 1.7 | null | Curative (C) | null | 2019-02-05 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 270024883 | TRIFLURIDINE TIPIRACIL |
| 270018526 | 270010682 | 1.94 | 44.6 | Palliative (P) | null | 2018-08-05 | MPV (cycle 5-9) - maintenance | null | null | 270024893 | PACLITAXEL |
| 270018527 | 270014989 | null | 56 | Curative (C) | 2018-03-12 | 2018-04-01 | Raltitrexed | 02 | N | 270025071 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270018528 | 270010694 | null | 45 | Adjuvant (A) | 2018-09-30 | 2018-11-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 270025100 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270018529 | 270010694 | 1.6 | 80 | Curative (C) | 2016-08-08 | 2016-09-12 | IBRUTINIB | 02 | N | 270025100 | PACLITAXEL |
| 270018530 | 270014992 | null | -1 | Disease modification (D) | 2014-11-02 | 2014-11-07 | Bevacizumab + Cape + Oxali 14day | N | null | 270025111 | CARBOPLATIN + CETUXIMAB + FU |
| 270018531 | 270010698 | 1.76 | 74 | Curative (C) | 2014-04-30 | 2014-06-18 | CARBOPLATIN + RT | N | N | 270025117 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270018532 | 270010701 | 1.65 | null | Palliative (P) | 2017-03-09 | 2017-03-09 | Carbo F | N | N | 270025137 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270018533 | 270020089 | 1.48 | 84 | Palliative (P) | 2016-08-03 | 2016-10-04 | Enzalutamide | N | null | 270025142 | CISPLATIN + VINORELBINE |
| 270018534 | 270010709 | 1.58 | null | Disease modification (D) | 2018-06-23 | 2018-06-24 | ESPAC-4 TRIAL | N | null | 270025294 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270018535 | 270017278 | 1.62 | null | Not known (9) | 2014-05-24 | 2014-08-13 | CARBOPLATIN + RT | 02 | N | 270025433 | CARBO + FLUOROURACIL |
| 270018536 | 270015002 | 1.79 | 83 | null | 2019-06-08 | 2019-06-13 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 270025491 | CARBOPLATIN + CETUXIMAB + FU |
| 270018537 | 270017280 | 1.76 | 59 | Disease modification (D) | 2016-10-07 | 2016-12-24 | CARBOPLATIN + RT | N | N | 270025663 | RALTITREXED |
| 270018538 | 270010724 | 1.73 | 109.2 | Curative (C) | 2019-01-16 | 2019-01-17 | CARBOPLATIN + RT | 02 | N | 270025740 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270018539 | 270015011 | 1.72 | 57.3 | Palliative (P) | 2017-10-11 | 2017-10-18 | CISPLATIN + ETOPOSIDE | N | N | 270025857 | CETUXIMAB + CISPLATIN + FLUOROURACIL |